BR0110129A - Composição farmacêutica - Google Patents

Composição farmacêutica

Info

Publication number
BR0110129A
BR0110129A BR0110129-3A BR0110129A BR0110129A BR 0110129 A BR0110129 A BR 0110129A BR 0110129 A BR0110129 A BR 0110129A BR 0110129 A BR0110129 A BR 0110129A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
release phase
paracetamol
unique
pharmacokinetic properties
Prior art date
Application number
BR0110129-3A
Other languages
English (en)
Inventor
Yue Shing Chan
Timothy James Grattan
Bounkhiene Sengmanee
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9890126&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0110129(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BR0110129A publication Critical patent/BR0110129A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Confectionery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"COMPOSIçãO FARMACêUTICA". Uma composição farmacêutica compreendendo uma fase de liberação imediata e uma fase de liberação prolongada de paracetamol é descrita que tem um perfil de dissolução in vitro singular resultando em propriedades farmacocinéticas vantajosas.
BR0110129-3A 2000-04-19 2001-04-12 Composição farmacêutica BR0110129A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0009522.4A GB0009522D0 (en) 2000-04-19 2000-04-19 Composition
PCT/EP2001/004302 WO2001080834A1 (en) 2000-04-19 2001-04-12 Composition

Publications (1)

Publication Number Publication Date
BR0110129A true BR0110129A (pt) 2002-12-31

Family

ID=9890126

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0110129-3A BR0110129A (pt) 2000-04-19 2001-04-12 Composição farmacêutica

Country Status (25)

Country Link
US (2) US7943170B2 (pt)
EP (1) EP1274402B1 (pt)
JP (1) JP2003531165A (pt)
KR (1) KR100845660B1 (pt)
CN (1) CN100335046C (pt)
AT (1) ATE438388T1 (pt)
AU (2) AU2001260212C1 (pt)
BR (1) BR0110129A (pt)
CA (1) CA2406373C (pt)
CO (1) CO5280073A1 (pt)
CY (1) CY1109483T1 (pt)
CZ (1) CZ303275B6 (pt)
DE (1) DE60139462D1 (pt)
DK (1) DK1274402T3 (pt)
EA (1) EA006103B1 (pt)
ES (1) ES2329971T3 (pt)
GB (1) GB0009522D0 (pt)
HK (1) HK1053601A1 (pt)
HU (1) HU230033B1 (pt)
MX (1) MXPA02010347A (pt)
NZ (1) NZ521799A (pt)
TW (1) TWI282286B (pt)
UA (1) UA76417C2 (pt)
WO (1) WO2001080834A1 (pt)
ZA (1) ZA200208084B (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0009522D0 (en) * 2000-04-19 2000-06-07 Smithkline Beecham Plc Composition
US8487002B2 (en) 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
TWI319713B (en) 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US20040186180A1 (en) * 2003-03-21 2004-09-23 Gelotte Cathy K. Non-steroidal anti-inflammatory drug dosing regimen
CN100348974C (zh) * 2003-09-30 2007-11-14 北京东方凯恩医药科技有限公司 一种药物组合物的检测方法
US20050095299A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
CN101242856A (zh) 2005-09-09 2008-08-13 莱博法姆公司 持续药物释放的组合物
US20080057122A1 (en) * 2006-08-31 2008-03-06 Aaipharma Inc. Acetaminophen pharmaceutical compositions
US8895066B2 (en) * 2007-10-16 2014-11-25 Paladin Labs Inc. Bilayer composition for the sustained release of acetaminophen and tramadol
RU2010129907A (ru) 2007-12-17 2012-01-27 Лабофарм Инк. (CA) Лекарственная форма с контролируемым высвобождением, предотвращающая неправильное употребление
JP2011511782A (ja) 2008-02-12 2011-04-14 アボット・ラボラトリーズ 長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途
CN102105136B (zh) * 2008-03-11 2014-11-26 蒂宝制药公司 包含非-阿片类止痛剂和阿片类止痛剂的组合的胃滞留型缓释剂型
US8372432B2 (en) 2008-03-11 2013-02-12 Depomed, Inc. Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
CA2746888C (en) 2008-12-16 2015-05-12 Labopharm (Barbados) Limited Misuse preventative, controlled release formulation
EA029018B1 (ru) * 2009-02-13 2018-01-31 Ромарк Лабораториз Л.С. Фармацевтические составы нитазоксанида с контролируемым высвобождением
PL399450A1 (pl) * 2009-08-31 2013-01-21 Depomed, Inc Utrzymujace sie w zoladku kompozycje farmaceutyczne do natychmiastowego i przedluzonego uwalniania acetaminofenu
US8597681B2 (en) 2009-12-22 2013-12-03 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
US9198861B2 (en) 2009-12-22 2015-12-01 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
EA201391643A1 (ru) * 2011-05-06 2014-07-30 ГЛЭКСОСМИТКЛАЙН ЭлЭлСи Составы с замедленным высвобождением парацетамола
US9050335B1 (en) 2011-05-17 2015-06-09 Mallinckrodt Llc Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia
US8741885B1 (en) 2011-05-17 2014-06-03 Mallinckrodt Llc Gastric retentive extended release pharmaceutical compositions
US8858963B1 (en) 2011-05-17 2014-10-14 Mallinckrodt Llc Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
US20140206740A1 (en) * 2011-07-30 2014-07-24 Neurovance, Inc. Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters
CN104853752B (zh) * 2012-10-18 2018-10-23 艾伯维公司 嘧啶二酮衍生物化合物的制剂
WO2016042570A1 (en) * 2014-09-16 2016-03-24 Suresh Pareek Extended release formulation of acetaminophen
AU2017230974B2 (en) * 2016-03-09 2022-02-03 Nls-1 Pharma Ag A mazindol IR/SR multilayer tablet and its use for the treatment of attention deficit/hyperactivity disorder (ADHD)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2058562B (en) * 1979-09-14 1983-11-30 Beecham Group Ltd Pharmaceutical compositions containing paracetamol and ascorbic acid
US4786503A (en) 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4820522A (en) 1987-07-27 1989-04-11 Mcneilab, Inc. Oral sustained release acetaminophen formulation and process
EP0418596A3 (en) 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
US5009895A (en) * 1990-02-02 1991-04-23 Merck & Co., Inc. Sustained release with high and low viscosity HPMC
US5900425A (en) 1995-05-02 1999-05-04 Bayer Aktiengesellschaft Pharmaceutical preparations having controlled release of active compound and processes for their preparation
US5773031A (en) 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
BE1011045A3 (fr) 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
FR2766708B1 (fr) * 1997-07-30 2000-05-05 Galenix Dev Composition contenant de l'hydroxypropylcellulose, de l'hydroxypropylmethylcellulose et/ou de l'ethylcellullose a titre d'agents desintegrants, et procede d'obtention
US5945123A (en) 1998-04-02 1999-08-31 K-V Pharmaceutical Company Maximizing effectiveness of substances used to improve health and well being
US6126967A (en) 1998-09-03 2000-10-03 Ascent Pediatrics Extended release acetaminophen particles
US6254891B1 (en) 1998-09-03 2001-07-03 Ascent Pediatrics, Inc. Extended release acetaminophen
GB0009522D0 (en) * 2000-04-19 2000-06-07 Smithkline Beecham Plc Composition
US7897172B2 (en) 2004-05-18 2011-03-01 L. Perrigo Company Tablets exhibiting reduced drug release variability

Also Published As

Publication number Publication date
HUP0300698A3 (en) 2004-09-28
AU2001260212C1 (en) 2020-07-16
GB0009522D0 (en) 2000-06-07
EA006103B1 (ru) 2005-08-25
CN1426298A (zh) 2003-06-25
CA2406373A1 (en) 2001-11-01
ZA200208084B (en) 2003-10-08
CN100335046C (zh) 2007-09-05
US20110177168A1 (en) 2011-07-21
ATE438388T1 (de) 2009-08-15
JP2003531165A (ja) 2003-10-21
CY1109483T1 (el) 2014-08-13
HU230033B1 (hu) 2015-05-28
EP1274402B1 (en) 2009-08-05
WO2001080834A1 (en) 2001-11-01
AU2001260212B2 (en) 2006-09-21
US7943170B2 (en) 2011-05-17
EP1274402A1 (en) 2003-01-15
UA76417C2 (en) 2006-08-15
CO5280073A1 (es) 2003-05-30
DE60139462D1 (de) 2009-09-17
MXPA02010347A (es) 2003-04-25
DK1274402T3 (da) 2009-11-16
PL358123A1 (en) 2004-08-09
KR100845660B1 (ko) 2008-07-10
KR20030009440A (ko) 2003-01-29
AU6021201A (en) 2001-11-07
HUP0300698A2 (hu) 2003-07-28
CZ303275B6 (cs) 2012-07-11
US20040202716A1 (en) 2004-10-14
CA2406373C (en) 2010-06-29
ES2329971T3 (es) 2009-12-03
CZ20023470A3 (cs) 2003-03-12
HK1053601A1 (en) 2003-10-31
EA200200954A1 (ru) 2003-04-24
TWI282286B (en) 2007-06-11
NZ521799A (en) 2004-12-24

Similar Documents

Publication Publication Date Title
BR0110129A (pt) Composição farmacêutica
BR0107869A (pt) Composições farmacêuticas eletrogiradas
CY2009015I1 (el) Φαρμακευτικος συνδυασμος αιθινυλεστραδιολης και δροπιρενονης για χρηση ως αντισυλληπτικο
FR2834212B1 (fr) Utilisation d'une poudre a liberation immediate dans des compositions pharmaceutiques et nutraceutiques
GB2365772A (en) Factor
ES2187201T3 (es) Empleo de esteroles y de esterolesteres a nanoescala.
TWI235068B (en) Sustained-release pharmaceutical composition
BR9811803A (pt) Comprido multiparticular aperfeiçoado de dissolução rápida
BR0112054A (pt) Composição formadora de micelas, e métodos para a administração e a proteção de um agente terapêutico
CY1108918T1 (el) Φαρμακευτικοι συνδυασμοι οξυκωδονης και ναλοξονης
DE60143393D1 (de) Modifizierte formen pharmazeutisch aktiver agenzien und verwendungen dafür
DK0792145T3 (da) Transdermal resorption af aktivstoffer fra underafkølede smelter
BR9804802A (pt) Composi-Æo de libera-Æo sustentada de drogas encapsuladas em micropoarticulas de cido hialuronico
BR0007294A (pt) Formulações farmacêuticas aperfeiçoadas
BR0012901A (pt) Medicamentos de ß - carbolina
BR0209283A (pt) Método para a fabricação de uma composição farmacêutica de baixa dosagem tendo distribuição e potência de droga uniforme
HUP0302635A3 (en) Phospholipid derivatives of valproic acid and mixtures thereof
BR0313428A (pt) Composições farmacêuticas de drogas semi-ordenados e polìmeros
BR9809571A (pt) Composição medicinal e processo para produzì-la
BR0113165A (pt) Derivados de 4-pirimidinamina, composições farmacêuticas e métodos relacionados
ITMI20010957A0 (it) Derivati dell'aoe-emodina e loro impiego nel trattamento di patologieneoplastiche
PL360289A1 (en) Arylpiperazine derivatives and their use as psychotropic agents
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
DE50015195D1 (de) Feste paroxetin enthaltende zubereitungen
BR0001144B1 (pt) Composicão farmacêutica de diclofenaco à base de vitamina-e, papaína e hialuronidase

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 13, 24 E 25 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25B Requested transfer of rights rejected

Owner name: SMITHKLINE BEECHAM P.L.C. (GB)

B25E Requested change of name of applicant rejected

Owner name: SMITHKLINE BEECHAM P.L.C. (GB)

B25B Requested transfer of rights rejected

Owner name: SMITHKLINE BEECHAM P.L.C. (GB)

B25E Requested change of name of applicant rejected

Owner name: SMITHKLINE BEECHAM P.L.C. (GB)